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Abstract: Amiodarone is an antiarrhythmic drug that exhibits highly complex and non-
exponential dynamics whose controlled administration has important implications for its clinical
use especially for long-term therapies. Its pharmacokinetics has been accurately modelled using a
fractional-order compartmental model. In this paper we design a fractional-order PID controller
and we evaluate its dynamical characteristics in terms of the stability margins of the closed loop
and the ability of the controlled system to attenuate various sources of noise and uncertainty.
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1. INTRODUCTION
1.1 Motivation
It is characteristic how Machado et al. [2011] open their
review on the recent history of fractional calculus say-
ing that “fractional calculus may be considered an old
and yet novel topic.” Although lots of mathematicians
have worked on this field, many fundamental questions
remain unanswered. From the point of view of applied
research the field is nowadays very active – it has been
only the last few decades that the scientific community
turned to fractional calculus seeking for a modeling so-
lution for phenomena that ordinary calculus had a hard
time to approach. Such complex phenomena are biological
membranes, viscoelastic materials, certain electrochemical
processes and biomedical phenomena (see Magin [2006]).
In 2010, Kytariolos et al. [2010] introduced fractional dy-
namics in the field of pharmacokinetic modelling point-
ing out the main reasons for the failure of the classical
IVIVC (In-Vitro In-Vivo Correlations) theory. The first
step to this direction was taken by Dokoumetzidis and
Macheras [2009]. In practice, non-linearities, anomalous
diffusion, fractional-order kinetics, diffusion accross fractal
manifolds, synergetic and competitive action and a great
many other factors render this approach not applicable
(see Dokoumetzidis and Macheras [2008]). Recently, a
significant number of relevant publications has emerged;
see Popovic´ et al. [2012], Verotta [2010a,b], Pereira [2010],
Dokoumetzidis et al. [2010b], Popovic´ et al. [2010].
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Fractional-order derivatives – which we shall define prop-
erly in the sequel – although seem to be a mere mathemati-
cal construction and a method of nonlinear modelling, pos-
sess, in fact, physical meaning and occur naturally through
physical phenomena. Hilfer [2000a] called attention on the
fact that such operators emerge naturally from the study of
anomalous diffusion and other phenomena (Hilfer [2000b]).
Fractional dynamics can be cast as Physiologically Based
Pharmacokinetic Models (PBPK) with fractional-order
derivatives (see Dokoumetzidis et al. [2010a]) where the
mass balance equations are rewritten using fractional-
order derivatives. This offers a mechanistic understanding
of the interplay among the main factors of drug distri-
bution, allows us to draw individualized concentration-
time profiles and study drug-drug interactions using the
fractional calculus approach. The “fractionalisation” of
pharmacokinetic equations though has to be done in a way
so that the mass preservation holds.
The problem of drug administration is purely a control
problem where the aim is to keep the drug concentration
at certain organs in the body close to the desired therapeu-
tical set-points while the concentration in other organs and
tissues does not exceed certain safety limits (see Sarimveis
et al. [2009]). The manipulated variable is the administered
dosage and the controlled variable is the concentration of
the drug in some tissue or organ of the body.
It is nowadays clear that accurate pharmacokinetic mod-
elling is essential for the understanding of the action of
a drug and is of major importance for of the establish-
ment of an efficient therapeutical administration course.
Feedback control is concededly a practice that enjoys wide
acceptance in medicine (see Sopasakis and Sarimveis [2012]
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and Dua et al. [2006]), though using linear integer-order
pharmacokinetic models.
In this paper we employ a fractional pharmacokinetic
model to describe the distribution of Amiodarone upon
intravenous administration, which has proven to be very
accurate when juxtaposed to actual data. Amiodarone
follows anomalous, non-exponential pharmacokinetic dy-
namics with major clinical implications as the drug may
overaccumulate in a long-term administration course. We
propose the use of a fractional PID controller and we
explore the dynamical characteristics of the closed-loop
system.
1.2 Fractional Dynamical Systems
The most exotic property of non-integer order derivatives
is that they are not local properties. The calculation
of (Dnf)(x0) (with n ∈ N) requires the knowledge of
f in an arbitrarily small region around x0, say (x0 −
ε, x0 + ε); this is not true for non-integer order derivatives
(Daf)(x0) (with a ∈ R). This property proves invaluable
when modeling phenomena with memory or other complex
dynamics. Using fractional calculus, one obtains some
peripheral vision in contrast to the local approach that
ordinary derivatives offer and the process is now modeled
using integro-differential equations.
Let us first define the generalised Riemann-Liouville
fractional-order integral operator which extends the n-th
order (n ∈ N) integral In which is given by the Cauchy
formula:
(Inf)(t) =
1
(n− 1)!
∫ t
0
(t− τ)n−1f(τ)dτ, t ≥ 0. (1)
Using the property of the Gamma function that Γ(n) =
(n−1)! for all n ∈ N we arrive at the following generalised
integral of real order α ∈ R:
(Iαf)(t) =
1
Γ(α)
∫ t
0
(t− τ)α−1f(τ)dτ, t ≥ 0. (2)
For α ∈ R let us denote by m = dαe the smallest natural
number m so that m ≥ α. The following operator is known
as the Caputo derivative of order α:
(Dαf)(t) = Im−α
dmf(t)
dtm
. (3)
This operator enjoys a number of good properties such
that it extends the integer-order derivative to arbitrary
real orders, it preserves analiticity, it is a linear operator,
it has the semigroup property (i.e., DαDβf = Dα+βf)
and D0 is the identity operator. It is of central importance
that the Laplace transformation of the Caputo fractional
derivative can be calculated by the following formula:
L [Dαf ] (s) = sαF (s)−
m−1∑
k=0
sα−k−1
dkf
dtk
∣∣∣∣
0
, (4)
where F (s) = (Lf)(s).
Such generalized derivation operators give rise to the cor-
responding class of functional relations known as fractional
differential equations and have the general form:
F (t, x,Dα1x, . . . ,Dαnx) = 0. (5)
Dynamical systems with fractional derivatives can be
represented in the following form:
H(Dα1 , . . . , Dαn)x = T (Dβ1 , . . . , Dβm)u (6)
where x and u stand for the output and input variables.
In this paper we consider the case of linear fractional
dynamical systems, i.e., we assume that H and T are
linear functions. Linear fractional dynamical systems can
be represented in the Laplace domain in terms of their
tranfer functions:
G(s) =
X(s)
U(s)
=
P (s)
Q(s)
, (7)
where P and Q are fractional polynomials, i.e., functions
of the form P (s) =
∑n
i=0 ais
bi with bi>0 for all i =
0, . . . , n, and X(s) = (Lx)(s) and U(s) = (Lu)(s). A very
interesting fact is that the achievement of equilibrium for
the output of the system (i.e., x˙(t) = 0) does not imply
that the input is also in equilibrium (i.e., u˙(t) = 0). This,
however, does not hinder us from studying the stability
of such systems in the BIBO (Bounded-Input Bounded-
Output) sense. To this end, let us define the open-loop
transfer function of the system:
Gol(s) = G(s)Gc(s), (8)
where Gc(s) is the transfer function of the controller. The
closed-loop transfer function, which relates the set-point
xsp with the response x, is:
Gcl(s) =
Gc(s)G(s)
1 +Gc(s)G(s)
. (9)
Various stability criteria have been postulated; in this
paper we shall use a Bode-type criterion which applies
to Gol (see Monje et al. [2010]):
Criterion 1. (BIBO Stability Criterion). Assume there ex-
ists a frequency ωco > 0 so that argGol(ıωco) = −pi
(This will be referred to as the crossover frequency of the
system). If |Gol(ıωco)| < 0db, then Gcl is BIBO-stable.
1.3 Numerical Simulations
In certain simple cases, the solution of fractional differen-
tial equations and initial value problems can be performed
analytically – usually in terms of the Mittag-Leffler special
function:
Ea,b(z) =
∑
k∈N
zk
Γ(ak + b)
. (10)
For instance, it is:
L−1 s
a−b
sa − λ = t
b−1Ea,b(λta). (11)
In a more general case, however, it is not possible to
derive analytical expressions for the solution. Aoun et al.
[2004] provide a thorough review of numerical methods
for the solution of fractional differential equations. A
very widespread approach consists in approximating the
fractional dynamics by some integer one. The Oustaloup
filter (see Oustaloup et al. [2000], Merrikh-Bayat [2012])
is a well established technique for the approximation of
fractional transfer functions by integer ones in a specified
range of operating frequencies.
1.4 Fractional-PID Controllers
Fractional PID controllers were introduced by Podlubny
[1999] and are generalisations of the standard PID. A
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fractional PID controller, or PIλDµ has a tranfer function
of the following form:
Gc(s) = Kp +
Ki
sλ
+Kds
µ, (12)
where Kp, Ki, Kd, λ and µ are positive tuning parameters,
and it produces the control action:
u(t) = Kp(t) +KiI
λ(t) +KdD
µ(t), (13)
where (t) is the deviation of the system’s output from the
set-point xsp(t) defined as (t) := xsp(t)−x(t). A fractional
PID controller involves 5 tuning parameters so it offers
greater flexibility by enabling us to determine both its low
and high-frequency gains. One of the most well-established
methods for the tuning of fractional PID controller is the
minimisation of a performance index involving the step
response of the closed-loop sytem. A standard choice is
the ITAE (Integral Time Absolute Error) index defined
as:
Jitae :=
∫ ∞
0
τ(τ)dτ. (14)
This leads to the formulation of the following optimisation
problem:
J?itae := min
Kp,Ki,Kd,λ,µ
Jitae, (15)
provided that the choice of parameters leads to a stable
closed-loop system. Such optimisation problems are non-
convex and their numerical solution depends on the initial
estimate; it is therefore recommended to try a multiplitude
of initial values. Monje et al. [2010] suggest that there may
be more than one acceptable parametrization.
The optimisation of the ITAE criterion can be carried out
along with some additional requirements so as to guarantee
certain desirable dynamical characteristics for the closed-
loop. Vale´rio and da Costa [2006] prescribe a set of 5
requirements for the tuning of fractional PID controllers
which attenuate the in-loop noise and damp external
noises. Noise rejection in the closed loop is guaranteed by
the following condition:
Mh := |Gcl(ıωh)| < η, (16)
where ωh is an arbitrarily chosen high frequency and η is
a design parameter. We also require that there should be
a crossover frequency ωco and the gain margin be equal
to a given value (greater than 1). What is the same we
postulate a similar requirement for the phase margin. The
controller has also to compensate parametric uncertainties
that can be the cause of inaccurate modelling or time-
varying dynamics of the controlled process. To enforce this
robustness qualification we require that:
Mz :=
d
dω
arg (Gol(ıω))
∣∣∣∣
ω=ωco
< ζ, (17)
where ζ > 0 is a design parameter. Finally, the closed-loop
system has to compensate for output disturbances, which
are in principle of low frequency (see A˚stro¨m [2002]). To
this end, we require that the sensitivity function of the
system, defined as
Gsens(s) :=
1
1 +Gol(s)
, (18)
exhibit low gain at low frequencies, i.e.,
M` := |Gsens(ıω`)| < ϑ (19)
where ω` is some, arbitrarily chosen, low frequency and ϑ
is a properly small design parameter.
Table 1. PK Parameters of Amiodarone
Parameter Value
a 0.5870
k10 1.4913day
 1
k12 2.9522day
 1
k21 0.4854day
 a
These requirements need to be taken into account while
tuning a fractional PID controller. This way, the opti-
misation problem (15) is solved subject to the nonlinear
constraints (16) to (19).
2. FEEDBACK CONTROL OF AMIODARONE
ADMINISTRATION
Amiodarone is an antiarrhythmic agent (see Ku¨hlkamp
et al. [1999]) which can be administered either intra-
venously (i.v.) or orally. Amiodarone is well-known for its
highly nonlinear non-exponential dynamics and singular
long-term accumulation pattern. Recently, Dokoumetzidis
et al. [2010a] modelled the pharmacokinetic distribution
of Amiodarone with a fractional compartmental model
following a single i.v. and a single oral dose. The com-
partmental topology of the model is presented in Figure 1.
Let A1 and A2 be the amounts of Amiodarone (in ng)
in the plasma and the tissues respectively and u be the
administration rate (in ng/day). We assume that the drug
is administered directly into the central (plasma) com-
partment while the control objective is the concentration
of the drug in the tissues attains a prescribed value (set-
point). The fractional dynamical model we employ reads
as follows:
dA1
dt
=−(k12 + k10)A1 + k21 ·D1−aA2 + u, (20a)
dA2
dt
= k12A1 − k21 ·D1−aA2, (20b)
with a < 1. The terms “k21 · D1−aA2” correspond to
the fractional-order diffusion of Amiodarone from the
tissues to the central compartment, the term “k12A1”
is the rate at which Amiodarone is transfered from the
central compartment to the tissues and “k10A1” defines
the excretion rate. This dynamics is graphically presented
in Fig. 1. The parameters of the aforementioned model
are presented in Table 1. The transfer function of the
system which links the administration rate U(s) = Lu(t)
to the concentration of Amiodarone in the tissues Aˆ2(s) =
LA2(t) is:
G(s) =
1
k10
(
1
k21
sa + 1
)
1
k10k21
sa+1 + 1k10 s+
k10+k12
k10k21
sa + 1
(21)
Before the commencement of the administration course we
assume that the initial concentration of Amiodarone in the
organism is zero, i.e., A1(t) = A2(t) = 0 for all t ≤ 0.
We tuned a fractional PID controller for the control of the
concentration of Amiodarone in the central compartment
the parameters of which were chosen using the ITAE crite-
rion along with the additional constraints outlined above.
We chose the characteristic frequencies ω` = 0.01rad/day,
and ωh = 100rad/day and required that ϑ = −10db, η =
−20db and we also imposed the robustness requirement
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Table 2. Optimal Tuning Parameters
Parameter Value
Kp 50.5197
Ki 151.0551
Kd 0.0756
λ 0.9170
µ 0.7590
ζ = 1deg · rad−1 · day. The optimal tuning parameters of
the fractional controller are given in Table 2. The optimal
value of Jitae following the excitation of the system with a
step pulse of amplitude xsp = +0.1 was found to be 3.9713·
10−4ng. Using the Bode diagram of Gol shown in Fig 4
Fig. 1. Topology of the pharmacokinetic system used for
the derivation of the pharmacokinetic model (20).
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Fig. 2. Step-response of the closed-loop system for a change
of the set-point by +0.1 for various values of Kp.
The thick red line corresponds to the optimal value
K?p = 50.52. The amount of Amiodarone is in ng.
we calculated the phase and gain margins of the closed
loop as well as the crossover frequency. A gain margin as
high as 43.9db should be considered excellent and implies
that the closed loop will remain stable even in presence of
delay element as it is well away from instability. We may
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Fig. 3. The control action produced by the optimally tuned
fractional controller. The administration rate is in
ng/day.
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Fig. 4. Bode diagram: The blue dashed line corresponds
to the pharmacokinetic system and the thick green
solid line to the open-loop system in presence of the
optimally tuned PIλDµ controller. The phase margin
is 98◦ and the gain margin is 43.9db. The crossover
frequency is 16rad/day. It was found that Mz =
0.5deg · rad−1 · day
draw the same conclusion observing the high phase margin
of 98◦. The phase margin translates into the maximum
delay that the closed-loop can take remaining stable; this
is calculated by the formula:
τd,max =
Mp
ω1
= 3.37day (22)
where ω1 = 0.43rad/day is the frequency at which
|Gol(ıω1)| = 0db and Mp is the phase margin in rad.
As one can see in Fig. 5, the closed-loop transfer func-
tion exhibits very low gain (<−60db) at high frequencies
(>ωh), thus filtering out high-frequency noise signals in
the closed loop and/or noise that comes with the set-point.
Despite of the quite high values of the stability margins,
the system responds satisfactorily fast. Due to the high
gain margin, we can increase the controller’s gain so as
19th IFAC World Congress
Cape Town, South Africa. August 24-29, 2014
8424
−80
−60
−40
−20
0
M
ag
ni
tu
de
 (d
B)
103 104 105 106 107
−225
−180
−135
−90
−45
0
Ph
as
e 
(de
g)
Bode Diagram
Frequency  (rad/day)
Fig. 5. Bode diagram of the closed-loop transfer func-
tion. Note that at high frequencies the gain is lower
than −60db, thus, the controller attenuates the high-
frequency noise in the closed-loop or possible noise
that comes with xsp.
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Fig. 6. Bode diagram of the sensitivity function of the
system.
to obtain faster responses at the cost of a higher ITAE
value. The sensitivity function of the system exhibits low
gain (lower than −20db) at low frequencies as one can
see in Fig. 6 which, in turn, implies that the system can
attenuate output disturbacens.
All time-domain simulations were performed using an
Oustaloup filter in the frequency range 10−3 ∼ 103rad/day.
For the frequency-domain calculations no approximation
was necessary.
3. CONCLUSION
Fractional Systems theory enables us to model nonlinear
processes with (infinite) memory such as anomalous diffu-
sion and deep tissue trapping and presents great perspec-
tives for pharmacokinetic modelling. Such systems can be
used for the formulation of control problems where the goal
is to maintain a constant drug concentration in a tissue of
organ of the body.
In this paper we designed a fractional-order PIλDµ-type
controller for the stabilisation of the concentration of
Amiodarone whose pharmacokinetic distribution in the
organism is described by a fractional-order model and we
presented closed-loop simulations. The designed controller
not only has a high gain margin but also exhibits excellent
behaviour with respect to noise rejection in the closed
loops and attenuation of externally applied disturbances.
The proposed control approach is a good candidate for
the control of other drugs that follow such fractional-
order dynamics such as Mibefradil (Fuite et al. [2002]) or
Diclofenac (Popovic´ et al. [2010]).
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